GLP-1 drugs are projected to become one of the largest therapeutic markets in pharmaceutical history, with some estimates suggesting global sales could exceed $80100 billion annually within the next decade
Prediabetes also increases the risk for other health conditions: High blood pressure Heart disease Kidney failure Metabolic syndrome Nonalcoholic fatty liver disease Obesity or excessive weight gain Unhealthy cholesterol levels While prediabetes is common and may lead to serious health risks, its difficult to diagnose since its often symptomless
"Better" depends on your health history, goals, and what is safely available
Mounjaro stays in your system for about three to four weeks after your last dose, so appetite usually returns gradually over the first month
Once depleted, your body must shift to fat oxidation as the primary fuel source
An aromatase inhibitor like Anastrozole corrects this when bloodwork confirms elevated estradiol levels